12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/17/2024
8:31 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:00 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
08/19/2024
4:14 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/12/2024
3:40 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/03/2024
7:39 AM | Checkpoint Therapeutics (Filer)
| Form 424B5 | |
07/03/2024
7:44 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
7:00 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:01 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:46 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
8:01 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
3:05 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/24/2024
3:06 PM | Checkpoint Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/17/2024
4:13 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
05/16/2024
6:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:34 PM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:35 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:31 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
6:30 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
04/02/2024
5:00 AM | Checkpoint Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
5:03 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
03/29/2024
4:03 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/22/2024
5:23 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
5:24 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SC 13D/A | |
03/22/2024
4:19 PM | Checkpoint Therapeutics (Filer)
| Form PRE 14A | |
AI breakthrough about to upend industry (Ad) Everyone is talking about AI right now.
The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI.
But here’s the thing. I urge you to watch it now. |
03/22/2024
4:13 PM | Checkpoint Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
7:52 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:00 PM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/01/2024
7:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
7:31 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
1:24 PM | ARMISTICE CAPITAL, LLC (Filed by)
Checkpoint Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024
4:00 PM | Checkpoint Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/02/2024
7:15 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
7:05 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/02/2024
7:10 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:15 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2024
4:00 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:01 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free CKPT Stock Alerts